Zachary Brennan has joined Politico to cover FDA regulations as part of the company’s expanded coverage of pharma policy. Brennan will be enhancing Politico’s pharma coverage during the ongoing pandemic and will also be acting as an expert contributor to Politico’s Agency IQ platform.
His new role begins this week.
Currently, he holds the post of managing editor at the Regulatory Affairs Professionals Society. He is also the author of FDA-focused publication, Regulatory Focus.
Before joining RAPS, Brennan was a pharmaceutical editor at William Reed Business Media Focus. He also served as an international editor at FDAnews and as a speechwriter at the U.S. Department of Transportation.
In addition, he was an editor with The Bulletin News Network and held the post of staff writer at The Advisory Board Company.
Brennan is a B.A. in English from Northwestern University.
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…
Members of the CoinDesk editorial team have sent a letter to the CEO of its…